Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Achieve Life Sciences, Inc. (ACHV)

4.92   0.21 (4.46%) 03-24 16:00
Open: 4.61 Pre. Close: 4.71
High: 5 Low: 4.52
Volume: 71,356 Market Cap: 88(M)

Technical analysis

as of: 2023-03-24 4:23:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.5     One year: 7.59
Support: Support1: 4.71    Support2: 4.17
Resistance: Resistance1: 5.57    Resistance2: 6.5
Pivot: 4.67
Moving Average: MA(5): 4.61     MA(20): 4.73
MA(100): 3.7     MA(250): 4.71
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 48.9     %D(3): 36
RSI: RSI(14): 54.6
52-week: High: 8.13  Low: 2
Average Vol(K): 3-Month: 103 (K)  10-Days: 94 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ACHV ] has closed below upper band by 31.1%. Bollinger Bands are 13% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.01 - 5.03 5.03 - 5.04
Low: 4.47 - 4.49 4.49 - 4.52
Close: 4.88 - 4.92 4.92 - 4.95

Company Description

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Headline News

Sun, 26 Mar 2023
Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment? - Simply Wall St

Mon, 20 Mar 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2022 Earnings Call Transcript - Yahoo Finance

Wed, 08 Mar 2023
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation - Yahoo Finance

Fri, 03 Mar 2023
Achieve Life Sciences Announces Presentation of the Phase 3 ... - GlobeNewswire

Mon, 13 Feb 2023
Francis Capital Management Updates Holdings in Achieve Life ... - Nasdaq

Tue, 07 Feb 2023
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ... - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 18 (M)
Shares Float 0 (M)
% Held by Insiders 8.4 (%)
% Held by Institutions 33.3 (%)
Shares Short 574 (K)
Shares Short P.Month 600 (K)

Stock Financials

EPS -3.85
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.1
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -1.28
PEG Ratio -0.2
Price to Book value 44.72
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2020-07-30
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.